COVID-19 Vaccine Candidate By Moderna Is Circa 95% Effective
Unic Press UK: Moderna, Inc. on Monday announced that its vaccine candidate against COVID-19, mRNA-1273, in a Phase 3 study…
Unic Press UK: Moderna, Inc. on Monday announced that its vaccine candidate against COVID-19, mRNA-1273, in a Phase 3 study…
Unic Press UK: Israel has signed a $237mn contract with Pfizer to purchase 8 million doses of Pfizer-BioNTech…
RT: The developers of Russia’s pioneering Sputnik V coronavirus vaccine say their formula appears to show 92 percent…
Unic Press UK: The European Commission would today seal a contract to buy 300 million doses of a potential…
Unic Press UK: A drug manufacturing leviathan Pfizer and its collaborator, BioNTech, have announced positive efficacy results…
RT: Russia’s coronavirus vaccines will not be offered commercially and won’t be given to tourists, the health ministry…